• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FDA starts review of Sanofi, AZ antibody for RSV prevention

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 05, 2023 at 10:32: AM
via The clock has started ticking on the FDA’s review of Sanofi and AstraZeneca’s one-shot antibody to protect newborns and infants from respiratory syncytial virus (RSV), with a decision due in the third quarter – just in time for the 2023/24 RSV season.

article source
 




Top Bottom
Back
Quote